AAREY DRUGS & PHARMACEUTICALS LTD

Scale -

Ebitda is 13.26 Rs Cr; Continuous Growth over 3 years; in Bottom Quartile

PAT is 3.97 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is -12 %
Quarterly Revenue is 44.63 Rs Cr; in Bottom Quartile
Quarterly Ebitda is 1.33 Rs Cr; in Bottom Quartile
PBT is 0.52 Rs Cr; 5 Year CAGR is -14 %

Profitability -

Quarterly Ebitda Margin is 3 %; Continuous Growth over 3 Quarters; in Bottom Quartile
Quarterly Profit margin is 2 %; Continuous Growth over 3 Quarters

PBDIT Margin is 2.8 %; in Bottom Quartile
PAT Margin is 0.84 %; 5 Year CAGR is -11 %

Return -

Asset Turnover is 161 %; Continuous Growth over 3 years; in Top Quartile

ROA is 1.33 %; Continuous Decline over 3 years; 5 Year CAGR is -16 %
ROE is 2.63 %; Continuous Decline over 3 years; 5 Year CAGR is -18 %

Efficiency -

Current Ratio is 1.81; Continuous Growth over 3 years
Inventory Turnover Ratio is 10.85; in Top Quartile

Solvancy -

Long term Debt is 0.97 Rs Cr; Annual Decline is -51 %; Continuous Decline over 3 years
Contingent Liabilities is 0 Rs Cr; in Bottom Quartile

Debt/Equity is 0.33; Annual Growth is 32 %; Continuous Growth over 3 years; 5 Year CAGR is 29 %
Total Debt is 49.96 Rs Cr; Annual Growth is 43 %; Continuous Growth over 3 years; 5 Year CAGR is 37 %

Quality -

Operating cashflow/PAT is 255 %; in Top Quartile
Other Expenses/Total Expenses is 2 %; in Bottom Quartile

Change in Inventories/Total Expenses is 1 %; Annual Growth is 137 %; in Top Quartile
Current Tax/PAT is 37 %; Continuous Growth over 3 years; in Top Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: